Results 1 to 10 of about 59,761 (296)

Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model. [PDF]

open access: yesPLoS ONE, 2013
Multimodal analgesia is designed to optimize pain relief by coadministering drugs with distinct mechanisms of action or by combining multiple pharmacologies within a single molecule. In clinical settings, combinations of monoamine reuptake inhibitors and
Fei Shen   +4 more
doaj   +1 more source

Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia

open access: yesIndian Journal of Psychiatry, 2021
Galactorrhea in nonpregnant woman of child-bearing age is related to various pathologies including the use of psychotropic. Although common with antipsychotics, galactorrhea with antidepressants was infrequent.
Subir Bhattacharjee   +2 more
doaj   +1 more source

Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction

open access: yesFrontiers in Pharmacology, 2021
Selective serotonin reuptake inhibitors (SSRIs) are a standard of care for the pharmacotherapy of patients suffering from Major Depressive Disorder (MDD). However, only one-half to two-thirds of MDD patients respond to SSRI therapy. Recently, a “multiple
Thanh Thanh L. Nguyen   +5 more
doaj   +1 more source

Serotonin Reuptake Inhibitor Increases Pseudarthrosis Rates in Anterior Cervical Discectomy and Fusions [PDF]

open access: yesAsian Spine Journal, 2023
Study Design Retrospective cohort. Purpose To determine (1) the effects of serotonin reuptake inhibitors in pseudarthrosis rates after anterior cervical decompression and fusion (ACDF) and (2) to identify patient-reported outcome measures in patients ...
Mark James Lambrechts   +15 more
doaj   +1 more source

Drug interaction between a selective serotonin reuptake inhibitor and a triptan leading to serotonin toxicity: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2021
Background Serotonin toxicity is a known side effect of selective serotonin reuptake inhibitors and has previously also been described as a possible side effect of 5-hydroxytryptamine receptor agonist (triptan) medications.
Gilbert Jin, Philip Stokes
doaj   +1 more source

Right and Left-Sided Carcinoid Heart Disease in the Setting of Selective Serotonin Reuptake Inhibitor Use

open access: yesJACC: Case Reports, 2020
Carcinoid heart disease is a complication of carcinoid syndrome. The role of selective serotonin reuptake inhibitors in carcinoid heart disease is unclear. We present a case of refractory heart failure due to right- and left-sided carcinoid heart disease
Jennifer Bell, MD   +4 more
doaj   +1 more source

Oromandibular dystonia associated with sertraline in an adolescent patient

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed to treat a variety of psychiatric disorders. Sertraline is a relatively selective serotonin reuptake inhibitor with some dopamine reuptake inhibitor activity.
Sevcan Sarısoy   +2 more
doaj   +1 more source

The Effects of Drugs on Behavior Maintained by Social Contact: Role of Monoamines in Social Reinforcement

open access: yesFrontiers in Behavioral Neuroscience, 2022
Drug use is highly concordant among members of adolescent and young adult peer groups. One potential explanation for this observation is that drugs may increase the reinforcing effects of social contact, leading to greater motivation to establish and ...
Jessica L. Sharp, Mark A. Smith
doaj   +1 more source

Different behavioral effects of maprotiline and fluxilan in rats [PDF]

open access: yesArchives of Biological Sciences, 2008
Serotonin and noradrenaline are involved in the mechanisms of action of most antidepressant drugs. We examined the effects of chronic treatment with maprotiline, a selective inhibitor of noradrenaline reuptake, and fluxilan, a selective inhibitor of ...
Spasojević Nataša   +2 more
doaj   +1 more source

Secondary Sources of Negative Symptoms in Those Meeting Criteria for a Clinical High-Risk Syndrome

open access: yesBiological Psychiatry Global Open Science, 2021
Background: Negative symptoms are diagnostic characteristics of schizophrenia. They can result from primary (i.e., idiopathic) or secondary (i.e., due to other factors such as depression, anxiety, psychosis, disorganization, medication effects) features ...
Tina Gupta   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy